Arkansas 2025 Regular Session

Arkansas House Bill HB1700

Introduced
3/6/25  
Refer
3/6/25  
Report Pass
3/12/25  
Engrossed
3/13/25  
Refer
3/13/25  
Report Pass
3/18/25  
Refer
3/19/25  
Report Pass
4/1/25  
Refer
4/9/25  
Report Pass
4/9/25  
Enrolled
4/10/25  
Chaptered
4/16/25  

Caption

To Amend The Prior Authorization Transparency Act; And To Clarify The Process Of An Adverse Determination Notice Under The Prior Authorization Transparency Act.

Impact

The amendments proposed by HB 1700 are intended to enhance the decision-making processes in healthcare, potentially leading to improved patient care. By mandating clearer communication and providing healthcare providers with direct points of contact for inquiries regarding adverse determinations, the bill seeks to facilitate a better understanding of denial reasons, ultimately assisting providers in advocating for necessary treatments for patients. Should the bill be enacted, it could lead to a more responsive and less bureaucratic healthcare authorization system within the state of Arkansas.

Summary

House Bill 1700 aims to amend the Prior Authorization Transparency Act, focusing on improving the clarity of the process involved in adverse determinations by utilization review entities. The bill specifies the requirements for notifications that need to be provided to healthcare providers when a service is denied due to questions regarding medical necessity or appropriateness. This includes the obligation for the utilization review entity to provide the name and contact information of a physician who can discuss the basis of the denial with the healthcare provider, increasing communication transparency in the healthcare system.

Sentiment

General sentiment towards HB 1700 appears positive, particularly among healthcare providers who support the need for clarity in communication regarding patient care decisions. Many in the medical community have expressed a desire for reforms that allow for more straightforward and comprehensible appeals processes when authorizations are denied. However, some skepticism exists regarding the willingness of utilization review entities to comply with these new requirements, and ongoing discussions suggest there are concerns about the practical enforcement of the amended regulations.

Contention

While overall support for the bill is evident, notable points of contention revolve around the potential administrative burden on utilization review entities. Critics argue that additional requirements could complicate and prolong the authorization process if not managed effectively, thus impacting timely patient care. Furthermore, there are discussions regarding how these amendments will interact with existing regulations and if they will result in a significant reduction in the number of adverse determinations or simply shift the focus of the complaints without making substantial improvements in patient access.

Companion Bills

No companion bills found.

Similar Bills

AR HB1301

To Amend The Prior Authorization Transparency Act.

AR HB1299

To Prohibit Healthcare Insurers From Exercising Recoupment For Payment Of Healthcare Services More Than One Year After The Payment For Healthcare Services Was Made.

AR HB1297

Concerning Artificial Intelligence, Algorithms, And Other Automated Technologies; And To Regulate Certain Practices Of Healthcare Insurers.

AR SB83

To Mandate Coverage For Breast Reconstruction Surgeries; To Require Prior Authorization For Breast Reconstruction Surgeries; And To Establish A Minimum Reimbursement Rate For Breast Reconstruction Surgeries.

AR HB1300

To Amend The Prior Authorization Transparency Act.

AR SB626

To Require Fair And Transparent Reimbursement Rates; To Ensure Parity Of Healthcare Services; To Amend The Billing In The Best Interest Of Patients Act; And To Declare An Emergency.

DE HB156

An Act To Amend Title 16 Of The Delaware Code Relating To The Healthcare Associated Infections Disclosure Act.

AL SB350

State Health Planning and Development Agency; collaboration among rural health care providers authorized; certification and supervision framework established, limited immunity from state and federal antitrust laws provided